P&K Skin Research Center Co., Ltd. (KOSDAQ:347740)

Market Cap	55.31B -13.5%
Revenue (ttm)	22.56B +12.1%
Net Income	3.82B -44.4%
EPS	131.66 -44.6%
Shares Out	28.88M
PE Ratio	14.55
Forward PE	n/a
Dividend	50.00 (2.61%)
Ex-Dividend Date	Dec 29, 2025

Volume	47,453
Open	1,875.00
Previous Close	1,926.00
Day's Range	1,875.00 - 1,966.00
52-Week Range	1,871.00 - 3,300.00
Beta	0.88
Analysts	n/a
Price Target	n/a
Earnings Date	May 29, 2026

About P&K Skin Research Center

P&K Skin Research Center Co., Ltd. engages in the evaluation and research of dermatological products in South Korea. It provides scientific information and technical support services for new cosmetic raw material development, functional cosmetics, and human application testing of quasi-drugs. The company performs human application, safety, efficacy, cosmeceuticals, health food, sensory, and in vitro tests. It also manufactures and sells raw pharmaceutical and cosmetic materials, and raw materials for health foods. The company was founded in 201...

• Industry: Commercial Physical and Biological Research
• Founded: 2010
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 347740

Financial Performance

In 2025, P&K Skin Research Center's revenue was 22.78 billion, an increase of 27.66% compared to the previous year's 17.85 billion. Earnings were 4.69 billion, a decrease of -19.45%.